Efficacy of Ultraviolet Germicidal Irradiation Devices to Reduce Respiratory Infections in Nursing Homes: Cluster Randomized Crossover Trial (RESPROTECT)
Impact du déploiement de Dispositifs d'Inactivation Des pathogènes de l'Air Par UVGI Dans la Lutte Contre Les Maladies Respiratoires Touchant Les résidents d'EHPAD
Sponsor: ANRS
This NA trial investigates Acute Respiratory Infections and is currently actively recruiting participants. ANRS leads this study, which shows 4 recorded versions since 2024 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
4 versions recorded-
Jan 2026 — Present [monthly]
Recruiting NA
-
Sep 2025 — Jan 2026 [monthly]
Recruiting NA
-
Jun 2025 — Sep 2025 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2024 — Jun 2025 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- ANRS
- French National Research Agency on Emerging Infectious Diseases
- Centre Hospitalier Emile Roux
For direct contact, visit the study record on ClinicalTrials.gov .